Home
RZLT
RZLT News

Latest Rezolute Inc. (NV) (RZLT) News on June 7, 2025

Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77%

Simply Wall St.

5 days ago

Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77%

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism

GlobeNewswire

10 days ago

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism

Rezolute, Inc. (RZLT): Analysts See 260% Upside Potential

Insider Monkey

18 days ago

Rezolute, Inc. (RZLT): Analysts See 260% Upside Potential

Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

GlobeNewswire

24 days ago

Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire

a month ago

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

Rezolute to Participate in Upcoming Investor Conferences

GlobeNewswire

a month ago

Rezolute to Participate in Upcoming Investor Conferences

Rezolute, Inc. Announces Closing of Underwritten Offering

GlobeNewswire

a month ago

Rezolute, Inc. Announces Closing of Underwritten Offering

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

GlobeNewswire

a month ago

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)

GlobeNewswire

a month ago

Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)

Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

2 months ago

Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans?

Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors

GlobeNewswire

2 months ago

Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors

Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

Rezolute Insiders Placed Bullish Bets Worth US$557.5k

Simply Wall St.

4 months ago

Rezolute Insiders Placed Bullish Bets Worth US$557.5k

Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

GlobeNewswire

4 months ago

Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference

GlobeNewswire

4 months ago

Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

GlobeNewswire

5 months ago

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire

6 months ago

FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully

Simply Wall St.

7 months ago

We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully

Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

Rezolute to Participate in Upcoming Investor Conferences

GlobeNewswire

7 months ago

Rezolute to Participate in Upcoming Investor Conferences

With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing

Simply Wall St.

8 months ago

With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study

GlobeNewswire

9 months ago

FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study

Pleasing Signs As A Number Of Insiders Buy Rezolute Stock

Simply Wall St.

9 months ago

Pleasing Signs As A Number Of Insiders Buy Rezolute Stock

Rezolute to Participate in Upcoming Investor Conferences

GlobeNewswire

9 months ago

Rezolute to Participate in Upcoming Investor Conferences

Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire

10 months ago

Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire

10 months ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

GlobeNewswire

a year ago

Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds

GlobeNewswire

a year ago

Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds

Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants

Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Edge Total Intelligence Inc. Updates Status of MCTO

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024

CNW Group

a year ago

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

ACCESSWIRE

a year ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Business Insider

a year ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Motley Fool

a year ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

GlobeNewswire

a year ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Unifor members vote to strike at Manitoba Hydro

CNW Group

a year ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly

AFP

a year ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Business Insider

a year ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Rezolute to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Rezolute to Participate in the Jefferies Global Healthcare Conference

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)

GlobeNewswire

a year ago

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

Rezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stake

Simply Wall St.

a year ago

Rezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stake

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

GlobeNewswire

a year ago

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying

Simply Wall St.

a year ago

Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying

Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)

GlobeNewswire

a year ago

Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

GlobeNewswire

a year ago

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

Business Wire

a year ago

Volato to Attend Stifel 2024 Transportation & Logistics Conference

American Resources Corporation's ReElement Technologies Executes MOU with Battery Damage Service GmbH

ACCESSWIRE

a year ago

American Resources Corporation's ReElement Technologies Executes MOU with Battery Damage Service GmbH

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

United Security Bancshares (UBFO) Reports Record Net Income for 2023

GuruFocus.com

a year ago

United Security Bancshares (UBFO) Reports Record Net Income for 2023

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer

GlobeNewswire

a year ago

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer

Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

GlobeNewswire

a year ago

Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

Business Wire

a year ago

Volato Expands Operational KPI Disclosures

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Simply Wall St.

a year ago

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Grove Collaborative Appoints Scott Giesler as General Counsel

Business Wire

a year ago

Grove Collaborative Appoints Scott Giesler as General Counsel

Business Wire

a year ago

Volato Partners with Banyan Air Service to Expand Maintenance Capabilities in Southeast for Growing Fleet of HondaJets

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

PR Newswire

a year ago

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

abrdn U.S. Closed End Funds Announce Distribution Payment Details

ACCESSWIRE

a year ago

abrdn U.S. Closed End Funds Announce Distribution Payment Details

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

GlobeNewswire

a year ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Spero Therapeutics Provides Corporate Update and 2024 Outlook

GlobeNewswire

a year ago

Spero Therapeutics Provides Corporate Update and 2024 Outlook

Business Wire

a year ago

Volato Reports Operational KPIs for 2023

ADC Therapeutics Provides Business Updates

GlobeNewswire

a year ago

ADC Therapeutics Provides Business Updates

FLANIGAN'S REPORTS EARNINGS

PR Newswire

a year ago

FLANIGAN'S REPORTS EARNINGS

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Volato Expands HondaJet Fleet by 50% to 24 Aircraft

Perma-Fix Joint Venture Receives Formal Award of European Waste Treatment Contract Valued at up to EUR 50 Million

GlobeNewswire

a year ago

Perma-Fix Joint Venture Receives Formal Award of European Waste Treatment Contract Valued at up to EUR 50 Million

Complete Solaria Announces an Equity Investment from Its Chairman

GlobeNewswire

a year ago

Complete Solaria Announces an Equity Investment from Its Chairman

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

ACCESSWIRE

a year ago

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

GlobeNewswire

a year ago

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

Veru Announces Proposed Public Offering of Common Stock

GlobeNewswire

a year ago

Veru Announces Proposed Public Offering of Common Stock

Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)

GlobeNewswire

a year ago

Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)

Business Wire

a year ago

Volato’s Vice President of Operations, Josh Newsteder, Appointed to HJOPA Board of Directors

SYLA Technologies Announces Business Collaboration with Private Fund Managed by BlackRock’s Real Estate Business

GlobeNewswire

a year ago

SYLA Technologies Announces Business Collaboration with Private Fund Managed by BlackRock’s Real Estate Business

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

GlobeNewswire

a year ago

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

Northern Dynasty Announces US$15 Million Convertible Notes Offering and Up To CAD$3.4 Million Private Placement

ACCESSWIRE

a year ago

Northern Dynasty Announces US$15 Million Convertible Notes Offering and Up To CAD$3.4 Million Private Placement

FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting

GlobeNewswire

a year ago

FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting

Business Wire

a year ago

Volato Launches Partner Benefits Program to Provide Elevated Luxury Experiences for Members

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

GlobeNewswire

2 years ago

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

Spire Global Awarded Space Services Contract by Lacuna Space to Build and Operate Six Satellites for a Dedicated IoT Constellation

Business Wire

2 years ago

Spire Global Awarded Space Services Contract by Lacuna Space to Build and Operate Six Satellites for a Dedicated IoT Constellation

Business Wire

2 years ago

Volato Announces Guaranteed Large Cabin Aircraft Availability Through Agreement with Fly Alliance

GlobeNewswire

2 years ago

CROWN PROPTECH ACQUISITIONS ANNOUNCES RECEIPT OF NOTICE OF LATE FILING FROM NYSE

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Smart Share Global Ltd Earnings Call

Smart Share Global Limited Announces Third Quarter 2023 Results

GlobeNewswire

2 years ago

Smart Share Global Limited Announces Third Quarter 2023 Results

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire

2 years ago

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Stonegate Healthcare Partners Announces Black Friday Biotech Special Report For an "XBI-MAS"

Newsfile

2 years ago

Stonegate Healthcare Partners Announces Black Friday Biotech Special Report For an "XBI-MAS"

United Bancorp, Inc. Increases its Fourth Quarter Cash Dividend Payment to $0.17 per Share, Which Produces a Forward Yield of 5.9%

ACCESSWIRE

2 years ago

United Bancorp, Inc. Increases its Fourth Quarter Cash Dividend Payment to $0.17 per Share, Which Produces a Forward Yield of 5.9%

5 REITs Under $5 Making Huge Gains This Month

Benzinga

2 years ago

5 REITs Under $5 Making Huge Gains This Month

Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day

GlobeNewswire

2 years ago

Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Rezolute Reports First Quarter Fiscal 2024 Results

GlobeNewswire

2 years ago

Rezolute Reports First Quarter Fiscal 2024 Results

Share on Social Networks: